A majority of the clinical cases of FXS reflect a lack of FMRP due to a large trinucleotide CGG-repeat expansion in the 5′ UTR of the gene, resulting in FMR1 gene silencing. The gene discussed is FMR1; the disease is fragile X syndrome.